SS-31 (Elamipretide): Targeting Cardiolipin to Restore Mitochondrial Bioenergetics
17th Jul 2026
Laboratory research looks closely at how cells maintain their mitochondrial structures. SS-31, also known as Elamipretide, is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) designed for this purpose. It targets the inner mitochondrial membrane. Standard antioxidants neutralise reactive oxygen species (ROS) randomly throughout the cell. SS-31 moves directly to the exact location where cells generate these free radicals. It binds specifically to cardiolipin, a fat molecule found only in the inner mitochondrial membrane. This connection helps maintain the physical shape of the mitochondrial folds, known as cristae. Preserving this structure is necessary to keep the electron transport chain running and stop the cell from triggering its own death cycle during test-tube studies. Scientists use this compound in cell cultures to track how mitochondria break down during metabolic stress and simulated oxygen deprivation.
Cardiolipin plays a specific role in how mitochondria function in isolated cells. It is a dual-structured fat molecule with a cone shape. This shape forces the inner mitochondrial membrane to curve and form cristae. These folds hold the structures that power the cell, known as the electron transport chain. Cardiolipin acts as an anchor, holding these components closely together in tight groups called respirasomes. This close grouping allows electrons to move quickly without leaking. However, cardiolipin takes damage easily from oxygen radicals because of its fat content and location. When oxygen radicals damage cardiolipin, it breaks away from the respiratory complexes. The tight groups fall apart. This physical breakdown causes more electrons to leak, which creates more radicals and lowers adenosine triphosphate (ATP) production. Cardiolipin also controls how mitochondria split and merge during laboratory observation. Cells use this splitting process to isolate and destroy damaged mitochondrial parts. If cardiolipin takes damage, the mitochondria break into pieces and stop producing enough energy. Protecting cardiolipin stops this chain reaction in isolated cell cultures.
When cells age in laboratory models, their mitochondria break down. As mitochondrial DNA (mtDNA) mutations build up over time, oxygen radicals destroy specific membrane fats. This combination stops the cell from producing energy. In isolated tests, this breakdown causes a severe loss of respiratory control. It also makes the mitochondrial permeability transition pore (mPTP) highly sensitive and unstable.
SS-31 works through basic electrical and water-repelling interactions. The peptide uses a specific sequence of amino acids that lets it cross cell membranes without needing a transport protein. Inside the mitochondrion, the positively charged parts of SS-31 attach to the negatively charged ends of cardiolipin. At the same time, its ring-shaped structures push into the fat layer to stabilise the molecule. This physical block stops cytochrome c from attaching to cardiolipin. Normally, cytochrome c moves electrons. However, if it attaches to damaged cardiolipin, it changes into an enzyme that destroys the membrane. SS-31 blocks this change and keeps the inner mitochondrial membrane intact. This keeps the electron transport complexes assembled so they can continue generating ATP. When SS-31 binds, it takes a highly specific position. It does not damage the normal membrane layer or change the electrical charge in healthy mitochondria. It simply blocks the exact spots where oxygen radicals normally attack cardiolipin fats. This targeted block matters most in simulated reperfusion models. In these lab tests, returning oxygen to starved cells creates a massive burst of radicals that would normally destroy cardiolipin instantly.
When scientists apply SS-31 to stressed cell cultures, they track several physical changes. First, the peptide restores ATP production by keeping the electron transport chain running smoothly. Second, it lowers the volume of mitochondrial oxygen radicals. This drop protects the surrounding proteins, fats, and DNA from oxidative damage. Third, the compound maintains the membrane's electrical charge, which stops the mPTP from opening. If this pore opens in a living cell, the mitochondrion swells and bursts. This releases cytochrome c into the main cell body, forcing the cell to die. By stopping this pore from opening, researchers can track how cells survive in test tubes with low oxygen or missing nutrients. Scientists use this chemical to model pathways tied to cardiovascular stress and age-related cell decline. Preserving the inner membrane structure also helps the mitochondrion import necessary proteins. The main cell body builds most mitochondrial proteins, and special transport channels must pull them across the mitochondrial membranes. This transport process requires a stable electrical charge and healthy membrane fats. By holding these factors steady, SS-31 allows the mitochondrion to import the enzymes it needs to maintain itself in laboratory models.
Precise handling and reconstitution dictate the success of any in-vitro experiment. Investigators sourcing high-purity reagents from aminopeptides platforms secure a stable baseline for their assays. SS-31 ships as a lyophilised powder to keep the molecular structure stable. Laboratory staff must reconstitute the peptide using a sterile bacteriostatic solution or phosphate-buffered saline (PBS), depending on the specific cell line. After mixing, staff must store the liquid aliquots at sub-zero temperatures to stop the peptide from degrading. Experimental design requires strict attention to concentration limits. In-vitro studies generally test concentrations between the nanomolar and low micromolar range. The exact amount depends on the cell type and the volume of induced mitochondrial stress. Testing different concentrations helps scientists measure the exact speed of mitochondrial recovery and locate the peptide's limits against oxidative damage.
The following section details standard scientific data regarding the laboratory application of this compound.
What is the relationship between elamipretide and cardiolipin?
The interaction is strictly physical and structural. Elamipretide binds directly to cardiolipin, a fat molecule located only on the inner mitochondrial membrane. This connection stops oxygen radicals from damaging the cardiolipin. The block keeps the mitochondrial folds intact and holds the respiratory complexes together to produce ATP.
What are the primary elamipretide peptide benefits observed in laboratory studies?
In-vitro assays show that the peptide restores ATP synthesis, lowers reactive oxygen species (ROS), and holds the mitochondrial membrane's electrical charge steady. It also stops the mitochondrial permeability transition pore (mPTP) from bursting open. In laboratory models, these actions help isolated cells survive extreme metabolic stress.
How is the elamipretide mechanism of action characterised in research?
Laboratory data defines the mechanism through basic electrical and water-repelling interactions. The positively charged parts of the peptide bind to the negatively charged ends of cardiolipin. At the same time, the aromatic rings push into the fat layer. This prevents cytochrome c from turning into a destructive enzyme, which protects the membrane from oxygen damage.
What is the recommended elamipretide concentration (often referred to as research dosage) for in-vitro experiments?
Laboratory staff do not use human dosing, as this compound remains strictly isolated to in-vitro testing. For cellular assays, researchers standardise concentrations between 10 nM and 100 nM. Investigators must identify the exact concentration through experimental testing based on the specific cell line and the applied metabolic stress protocol.
How does this research relate to other cellular pathways?
Mitochondrial stability heavily influences standard cellular functions. Investigators studying these pathways often track how preserving the mitochondria affects other cellular mechanisms. They compare this data against pathways regulated by growth factors or secretagogues to map the wider network of cell metabolism and survival in vitro.
Scientific References
- Szeto, H. H. (2014). First-in-class cardiolipin-protective compound (SS-31) for mitochondrial dysfunction. British Journal of Pharmacology, 171(8), 2029-2050. View published research
- Birk, A. V., et al. (2013). The mitochondrial-targeted compound SS-31 interacts with cardiolipin and modulates membrane biophysics. Journal of Biological Chemistry, 288(31), 22847-22859. View published research
- Chatfield, K. C., et al. (2019). Elamipretide (SS-31) improves mitochondrial function in Barth syndrome. Journal of Inherited Metabolic Disease, 42(6), 1066-1076. View published research
- Dai, D. F., et al. (2014). Mitochondrial-targeted peptide SS-31 prevents cardiolipin peroxidation and preserves mitochondrial structure in aging kidneys. Aging Cell, 13(6), 1037-1045. View published research
- Brown, D. A., et al. (2014). Mitochondrial targeting with SS-31 protects against cardiac ischemia-reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics, 19(3), 278-285. View published research
- Zhao, K., et al. (2004). Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane. Journal of Biological Chemistry, 279(33), 34682-34690. View published research
- Alam, M. T., et al. (2020). Elamipretide (SS-31) ameliorates mitochondrial dysfunction and cognitive decline in a mouse model of Alzheimer’s disease. Neurotherapeutics, 17(4), 1834-1848. View published research
⚠️ Research Use Only Disclaimer: All peptides and compounds are sold strictly for in-vitro laboratory research purposes only. Not intended for human or veterinary use, not a dietary supplement, and not approved to diagnose, treat, cure, or prevent any disease or condition. For use by qualified researchers in suitably equipped laboratory environments only. Amino Peptides Ltd operates in full compliance with UK MHRA regulations and applicable EU research chemical guidelines.